{
    "info": {
        "nct_id": "NCT06710548",
        "official_title": "Randomized Trial of REVITALIZE: A Telehealth Intervention to Reduce Fatigue Interference Among Adults With Advanced Ovarian Cancer on PARP Inhibitors",
        "inclusion_criteria": "* Adult patients (age ≥ 18 years) with ovarian, fallopian tube, or primary peritoneal cancers (hereafter ovarian cancer) who have completed primary therapy (surgery and chemotherapy).\n* Treated with a PARP inhibitor as maintenance therapy for ≥2 months and plan to continue for at least 7 months.\n* English-speaking.\n* Mean fatigue severity level ≥4 on the first three items of the Fatigue Symptom Inventory.\n* ECOG performance status of 0-2.\n* Willing to use a wireless pill bottle for PARP inhibitor medication.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Untreated clinical condition or comorbid condition that pre-dates PARP inhibitor use and could explain fatigue, as evaluated by their treating oncologist.\n* Patients with severe psychiatric conditions (e.g. untreated trauma unrelated to cancer, high or imminent suicidality) as evaluated by their treating oncologist, which require more intensive psychiatric treatment than the study can provide.\n* Patients with cognitive conditions (e.g. dementia), determined by their treating oncologist, such that they could not provide informed consent or complete the study procedures.\n* Inability to complete the first questionnaire within one week of consent.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Must be FEMALE",
            "criterions": [
                {
                    "exact_snippets": "Must be FEMALE",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "female"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Willing to use a wireless pill bottle for PARP inhibitor medication.",
            "criterions": [
                {
                    "exact_snippets": "Willing to use a wireless pill bottle for PARP inhibitor medication",
                    "criterion": "use of wireless pill bottle for PARP inhibitor medication",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* ECOG performance status of 0-2.",
            "criterions": [
                {
                    "exact_snippets": "ECOG performance status of 0-2",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Mean fatigue severity level ≥4 on the first three items of the Fatigue Symptom Inventory.",
            "criterions": [
                {
                    "exact_snippets": "Mean fatigue severity level ≥4 on the first three items of the Fatigue Symptom Inventory.",
                    "criterion": "mean fatigue severity level (first three items of the Fatigue Symptom Inventory)",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 4,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* English-speaking.",
            "criterions": [
                {
                    "exact_snippets": "English-speaking",
                    "criterion": "language ability",
                    "requirements": [
                        {
                            "requirement_type": "language",
                            "expected_value": "English"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adult patients (age ≥ 18 years) with ovarian, fallopian tube, or primary peritoneal cancers (hereafter ovarian cancer) who have completed primary therapy (surgery and chemotherapy).",
            "criterions": [
                {
                    "exact_snippets": "Adult patients (age ≥ 18 years)",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum age",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "with ovarian, fallopian tube, or primary peritoneal cancers (hereafter ovarian cancer)",
                    "criterion": "cancer diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": [
                                "ovarian cancer",
                                "fallopian tube cancer",
                                "primary peritoneal cancer"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "who have completed primary therapy (surgery and chemotherapy)",
                    "criterion": "primary therapy completion",
                    "requirements": [
                        {
                            "requirement_type": "completion",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "therapy type",
                            "expected_value": [
                                "surgery",
                                "chemotherapy"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Treated with a PARP inhibitor as maintenance therapy for ≥2 months and plan to continue for at least 7 months.",
            "criterions": [
                {
                    "exact_snippets": "Treated with a PARP inhibitor as maintenance therapy",
                    "criterion": "PARP inhibitor maintenance therapy",
                    "requirements": [
                        {
                            "requirement_type": "treatment history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "for ≥2 months",
                    "criterion": "duration of PARP inhibitor maintenance therapy",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "plan to continue for at least 7 months",
                    "criterion": "planned duration of PARP inhibitor maintenance therapy",
                    "requirements": [
                        {
                            "requirement_type": "planned duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 7,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Patients with severe psychiatric conditions (e.g. untreated trauma unrelated to cancer, high or imminent suicidality) as evaluated by their treating oncologist, which require more intensive psychiatric treatment than the study can provide.",
            "criterions": [
                {
                    "exact_snippets": "severe psychiatric conditions (e.g. untreated trauma unrelated to cancer, high or imminent suicidality)",
                    "criterion": "psychiatric condition",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "severe"
                        }
                    ]
                },
                {
                    "exact_snippets": "severe psychiatric conditions (e.g. untreated trauma unrelated to cancer, high or imminent suicidality) ... require more intensive psychiatric treatment than the study can provide",
                    "criterion": "need for psychiatric treatment",
                    "requirements": [
                        {
                            "requirement_type": "intensity of required treatment",
                            "expected_value": "> study can provide"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients with cognitive conditions (e.g. dementia), determined by their treating oncologist, such that they could not provide informed consent or complete the study procedures.",
            "criterions": [
                {
                    "exact_snippets": "Patients with cognitive conditions (e.g. dementia)",
                    "criterion": "cognitive conditions",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "determined by their treating oncologist, such that they could not provide informed consent or complete the study procedures",
                    "criterion": "ability to provide informed consent",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "determined by their treating oncologist, such that they could not ... complete the study procedures",
                    "criterion": "ability to complete study procedures",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Inability to complete the first questionnaire within one week of consent.",
            "criterions": [
                {
                    "exact_snippets": "Inability to complete the first questionnaire within one week of consent",
                    "criterion": "completion of the first questionnaire",
                    "requirements": [
                        {
                            "requirement_type": "timing",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "week"
                            }
                        },
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Untreated clinical condition or comorbid condition that pre-dates PARP inhibitor use and could explain fatigue, as evaluated by their treating oncologist.",
            "criterions": [
                {
                    "exact_snippets": "Untreated clinical condition or comorbid condition that pre-dates PARP inhibitor use and could explain fatigue",
                    "criterion": "clinical condition or comorbid condition",
                    "requirements": [
                        {
                            "requirement_type": "treatment status",
                            "expected_value": "untreated"
                        },
                        {
                            "requirement_type": "onset relative to PARP inhibitor use",
                            "expected_value": "pre-dates PARP inhibitor use"
                        },
                        {
                            "requirement_type": "potential to explain fatigue",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "as evaluated by their treating oncologist",
                    "criterion": "evaluation by treating oncologist",
                    "requirements": [
                        {
                            "requirement_type": "evaluation",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}